Xsensio announced that it closed a $7 million oversubscribed Series A financing round to support its patient monitoring ...
Xsensio SA, a Swiss deep-tech company pioneering near real-time continuous biochemical monitoring, today announced the ...
A research team at the Terasaki Institute, led by Dr. Vadim Jucaud in collaboration with Dr. Jing Yong Ye from the University of Texas San Antonio, has developed a new microfluidic-based biosensing ...
OXFORD, England & PASADENA, Calif.--(BUSINESS WIRE)--Rockley Photonics Holdings Limited (NYSE: RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced ...
Real-time monitoring of key biomarkers is a critical prerequisite for early disease diagnosis and personalized therapy. Early detection of liver function impairment particularly relies on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results